Characterization of Monoacylglycerol Lipase Inhibition Reveals Differences in Central and Peripheral Endocannabinoid Metabolism

Chemistry and Biology

Volumn 16, Issue 7, 2009, Pages 744-753

  Long, Jonathan Z ^a   Nomura, Daniel K ^a   Cravatt, Benjamin F ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

CELLBIO; CHEMBIO; MOLNEURO

Indexed keywords

1,3 BENZODIOXOLE DERIVATIVE; 2 ARACHIDONOYLGLYCEROL; 2-ARACHIDONYLGLYCEROL; ACYLGLYCEROL; ACYLGLYCEROL LIPASE; ARACHIDONIC ACID DERIVATIVE; ENDOCANNABINOID; ENZYME INHIBITOR; JZL 184; MONOACYLGLYCEROL; PIPERIDINE DERIVATIVE;

ANIMAL; ARTICLE; BRAIN; DRUG ANTAGONISM; METABOLISM; MOUSE;

ANIMALS; ARACHIDONIC ACIDS; BENZODIOXOLES; BRAIN; ENDOCANNABINOIDS; ENZYME INHIBITORS; GLYCERIDES; METABOLIC NETWORKS AND PATHWAYS; MICE; MONOACYLGLYCEROL LIPASES; MONOGLYCERIDES; PIPERIDINES;

MUS;

EID: 67651100845     PISSN: 10745521     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chembiol.2009.05.009     Document Type: Article

References (44)

1. Ahn K., Johnson D.S., Fitzgerald L.R., Liimatta M., Arendse A., Stevenson T., Lund E.T., Nugent R.A., Nomanbhoy T.K., Alexander J.P., et al. Novel mechanistic class of fatty acid amide hydrolase inhibitors with remarkable selectivity. Biochemistry 46 (2007) 13019-13030
2. Ahn K., Johnson D.S., Mileni M., Beidler D., Long J.Z., McKinney M.K., Weerapana E., Sadagopan N., Liimatta M., Smith S.E., et al. Discovery and characterization of a highly selective FAAH inhibitor that reduces inflammatory pain. Chem. Biol. 16 (2009) 411-420
3. Alexander J.P., and Cravatt B.F. Mechanism of carbamate inactivation of FAAH: implications for the design of covalent inhibitors and in vivo functional probes for enzymes. Chem. Biol. 12 (2005) 1179-1187
4. Bar-On P., Millard C.B., Harel M., Dvir H., Enz A., Sussman J.L., and Silman I. Kinetic and structural studies on the interaction of cholinesterases with the anti-Alzheimer drug rivastigmine. Biochemistry 41 (2002) 3555-3564
5. Blankman J.L., Simon G.M., and Cravatt B.F. A comprehensive profile of brain enzymes that hydrolyze the endocannabinoid 2-arachidonoylglycerol. Chem. Biol. 14 (2007) 1347-1356
6. Chen J.K., Chen J., Imig J.D., Wei S., Hachey D.L., Guthi J.S., Falck J.R., Capdevila J.H., and Harris R.C. Identification of novel endogenous cytochrome p450 arachidonate metabolites with high affinity for cannabinoid receptors. J. Biol. Chem. 283 (2008) 24514-24524
7. Cravatt B.F., Giang D.K., Mayfield S.P., Boger D.L., Lerner R.A., and Gilula N.B. Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides. Nature 384 (1996) 83-87
8. Cravatt B.F., Demarest K., Patricelli M.P., Bracey M.H., Giang D.K., Martin B.R., and Lichtman A.H. Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase. Proc. Natl. Acad. Sci. USA 98 (2001) 9371-9376
9. Devane W.A., Hanus L., Breuer A., Pertwee R.G., Stevenson L.A., Griffin G., Gibson D., Mandelbaum A., Etinger A., and Mechoulam R. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258 (1992) 1946-1949
10. Di Marzo V., Bisogno T., and De Petrocellis L. Endocannabinoids and related compounds: walking back and forth between plant natural products and animal physiology. Chem. Biol. 14 (2007) 741-756
11. Dinh T.P., Carpenter D., Leslie F.M., Freund T.F., Katona I., Sensi S.L., Kathuria S., and Piomelli D. Brain monoglyceride lipase participating in endocannabinoid inactivation. Proc. Natl. Acad. Sci. USA 99 (2002) 10819-10824
12. Dinh T.P., Kathuria S., and Piomelli D. RNA interference suggests a primary role for monoacylglycerol lipase in the degradation of the endocannabinoid 2-arachidonoylglycerol. Mol. Pharmacol. 66 (2004) 1260-1264
13. Eng J.K., McCormack A.L., and Yates J.R. An approach to correlate tandem mass spectral data of peptides with amino acid sequences in a protein database. J. Am. Soc. Mass Spectrom. 5 (1994) 976-989
14. Fegley D., Gaetani S., Duranti A., Tontini A., Mor M., Tarzia G., and Piomelli D. Characterization of the fatty acid amide hydrolase inhibitor cyclohexyl carbamic acid 3′-carbamoyl-biphenyl-3-yl ester (URB597): effects on anandamide and oleoylethanolamide deactivation. J. Pharmacol. Exp. Ther. 313 (2005) 352-358
15. Fredrikson G., and Belfrage P. Positional specificity of hormone-sensitive lipase from rat adipose tissue. J. Biol. Chem. 258 (1983) 14253-14256
16. Fredrikson G., Tornqvist H., and Belfrage P. Hormone-sensitive lipase and monoacylglycerol lipase are both required for complete degradation of adipocyte triacylglycerol. Biochim. Biophys. Acta 876 (1986) 288-293
17. Jessani N., Niessen S., Wei B.Q., Nicolau M., Humphrey M., Ji Y., Han W., Noh D.Y., Yates III J.R., Jeffrey S.S., et al. A streamlined platform for high-content functional proteomics of primary human specimens. Nat. Methods 2 (2005) 691-697
18. Karlsson M., Contreras J.A., Hellman U., Tornqvist H., and Holm C. cDNA cloning, tissue distribution, and identification of the catalytic triad of monoglyceride lipase. Evolutionary relationship to esterases, lysophospholipases, and haloperoxidases. J. Biol. Chem. 272 (1997) 27218-27223
19. Karlsson M., Reue K., Xia Y.R., Lusis A.J., Langin D., Tornqvist H., and Holm C. Exon-intron organization and chromosomal localization of the mouse monoglyceride lipase gene. Gene 272 (2001) 11-18
20. Ledent C., Valverde O., Cossu G., Petitet F., Aubert J.F., Beslot F., Bohme G.A., Imperato A., Pedrazzini T., Roques B.P., et al. Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice. Science 283 (1999) 401-404
21. Leung D., Hardouin C., Boger D.L., and Cravatt B.F. Discovering potent and selective reversible inhibitors of enzymes in complex proteomes. Nat. Biotechnol. 21 (2003) 687-691
22. Li W., Blankman J.L., and Cravatt B.F. A functional proteomic strategy to discover inhibitors for uncharacterized hydrolases. J. Am. Chem. Soc. 129 (2007) 9594-9595
23. Lichtman A.H., Sheikh S.M., Loh H.H., and Martin B.R. Opioid and cannabinoid modulation of precipitated withdrawal in delta9-THC and morphine-dependent mice. J. Pharmacol. Exp. Ther. 298 (2001) 1007-1014
24. Liu H., Sadygov R.G., and Yates III J.R. A model for random sampling and estimation of relative protein abundance in shotgun proteomics. Anal. Chem. 76 (2004) 4193-4201
25. Liu Y., Patricelli M.P., and Cravatt B.F. Activity-based protein profiling: the serine hydrolases. Proc. Natl. Acad. Sci. USA 96 (1999) 14694-14699
26. Long J.Z., Li W., Booker L., Burston J.J., Kinsey S.G., Schlosburg J.E., Pavon F.J., Serrano A.M., Selley D.E., Parsons L.H., et al. Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects. Nat. Chem. Biol. 5 (2009) 37-44
27. Mackie K. Distribution of cannabinoid receptors in the central and peripheral nervous system. Handb. Exp. Pharmacol. 168 (2005) 299-325
28. Mackie K. Cannabinoid receptors as therapeutic targets. Annu. Rev. Pharmacol. Toxicol. 46 (2006) 101-122
29. Matsuda L.A., Lolait S.J., Brownstein M.J., Young A.C., and Bonner T.I. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346 (1990) 561-564
30. Mechoulam R., Ben-Shabat S., Hanus L., Ligumsky M., Kaminski N.E., Schatz A.R., Gopher A., Almog S., Martin B.R., Compton D.R., et al. Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem. Pharmacol. 50 (1995) 83-90
31. Motaghedi R., and McGraw T.E. The CB1 endocannabinoid system modulates adipocyte insulin sensitivity. Obesity (Silver Spring) 16 (2008) 1727-1734
32. Munro S., Thomas K.L., and Abu-Shaar M. Molecular characterization of a peripheral receptor for cannabinoids. Nature 365 (1993) 61-65
33. Nomura D.K., Blankman J.L., Simon G.M., Fujioka K., Issa R.S., Ward A.M., Cravatt B.F., and Casida J.E. Activation of the endocannabinoid system by organophosphorus nerve agents. Nat. Chem. Biol. 4 (2008) 373-378
34. Nomura D.K., Hudak C.S., Ward A.M., Burston J.J., Issa R.S., Fisher K.J., Abood M.E., Wiley J.L., Lichtman A.H., and Casida J.E. Monoacylglycerol lipase regulates 2-arachidonoylglycerol action and arachidonic acid levels. Bioorg. Med. Chem. Lett. 18 (2008) 5875-5878
35. Okazaki H., Igarashi M., Nishi M., Tajima M., Sekiya M., Okazaki S., Yahagi N., Ohashi K., Tsukamoto K., Amemiya-Kudo M., et al. Identification of a novel member of the carboxylesterase family that hydrolyzes triacylglycerol: a potential role in adipocyte lipolysis. Diabetes 55 (2006) 2091-2097
36. Osei-Hyiaman D., Liu J., Zhou L., Godlewski G., Harvey-White J., Jeong W.I., Batkai S., Marsicano G., Lutz B., Buettner C., et al. Hepatic CB1 receptor is required for development of diet-induced steatosis, dyslipidemia, and insulin and leptin resistance in mice. J. Clin. Invest. 118 (2008) 3160-3169
37. Osuga J., Ishibashi S., Oka T., Yagyu H., Tozawa R., Fujimoto A., Shionoiri F., Yahagi N., Kraemer F.B., Tsutsumi O., et al. Targeted disruption of hormone-sensitive lipase results in male sterility and adipocyte hypertrophy, but not in obesity. Proc. Natl. Acad. Sci. USA 97 (2000) 787-792
38. Patricelli M.P., Giang D.K., Stamp L.M., and Burbaum J.J. Direct visualization of serine hydrolase activities in complex proteomes using fluorescent active site-directed probes. Proteomics 1 (2001) 1067-1071
39. Sugiura T., Kondo S., Sukagawa A., Nakane S., Shinoda A., Itoh K., Yamashita A., and Waku K. 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain. Biochem. Biophys. Res. Commun. 215 (1995) 89-97
40. Tabb D.L., McDonald W.H., and Yates III J.R. DTASelect and Contrast: tools for assembling and comparing protein identifications from shotgun proteomics. J. Proteome Res. 1 (2002) 21-26
41. Tornqvist H., and Belfrage P. Purification and some properties of a monoacylglycerol-hydrolyzing enzyme of rat adipose tissue. J. Biol. Chem. 251 (1976) 813-819
42. Verty A.N., Singh M.E., McGregor I.S., and Mallet P.E. The cannabinoid receptor antagonist SR 141716 attenuates overfeeding induced by systemic or intracranial morphine. Psychopharmacology (Berl.) 168 (2003) 314-323
43. Zhang D., Saraf A., Kolasa T., Bhatia P., Zheng G.Z., Patel M., Lannoye G.S., Richardson P., Stewart A., Rogers J.C., et al. Fatty acid amide hydrolase inhibitors display broad selectivity and inhibit multiple carboxylesterases as off-targets. Neuropharmacology 52 (2007) 1095-1105
44. Zimmer A., Zimmer A.M., Hohmann A.G., Herkenham M., and Bonner T.I. Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice. Proc. Natl. Acad. Sci. USA 96 (1999) 5780-5785